Particulars
AMRUTANJAN HEALTH CARE
Year of establishment
1936
Revenue for the current year
26.1749(USD in millions)
Market Capitalization
1686.607351( RS. in millions)
Industry
Pharmaceuticals
Total Income
1393.532573(Million rupees on year ending march 2013)
Net Profit
121.196237
INTRDUCTION: There are two types of prospective financial statements.
1. Projected financial statement
2. Forecasted financial statement
These statements attempt to reflect company’s expected financial position and expected results of operations.
The projected financial statement is summary. It is the summary of revenue and expenses for the budgeted period. Projected financial statement includes the Balance Sheet, income statement and cash flow statement for the budgeted period.
Balance Sheet shows assets liabilities and equity at a particular point of time.
DETAILS ABOUT AMRUTANJAN’S BUSINESS
2012
2013 AMRUTANJAN Pain balm- 1053.28 (RS. In million) AMRUTANJAN Pain balm- 1086.10 (RS. In million)
Inhaler & others- 86.55(RS. In million)
Beverages -201.70(RS. In million)
Agency Products - 60. 38 (RS. In million)
Agency Products - 69. 02 (RS. In million)
Other operating revenue- 2.15(RS. In million)
Inhaler & others- 54.19(RS. In million)
Chemicals- 1.93(RS. In million)
Other operating revenue- 9.90(RS. In million)
Superficial Analysis of amrutanjan for recent two years:
From the above quoted table i can see that in the year 2013 AMRUTANJAN has stopped doing business of chemicals and they have started doing business in beverages…secondly there is growing profitability in all the segments of AMRUTANJAN business except inhaler & other. I need to investigate that why AMRUTANJAN has stopped chemical business and why they are gaining profit in beverages business? What are the future prospective of beverages business for AMRUTANJAN co.? Why inhaler & other business has shown revenue